{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:08Z","timestamp":1790649788903,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.2353\/ajpath.2007.060455","type":"journal-article","created":{"date-parts":[[2007,2,23]],"date-time":"2007-02-23T15:31:52Z","timestamp":1172244712000},"page":"830-842","source":"Crossref","is-referenced-by-count":121,"title":["Involvement of Hypoxia-Inducible Transcription Factors in Polycystic Kidney Disease"],"prefix":"10.1016","volume":"170","author":[{"given":"Wanja Michael","family":"Bernhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Sean","family":"Wiesener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Campean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Chee Meng","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Willam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Gretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2007.060455_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2007.060455_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199307293290508","article-title":"Autosomal dominant polycystic kidney disease","volume":"329","author":"Gabow","year":"1993","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2007.060455_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2165\/00003495-200464120-00002","article-title":"Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications","volume":"64","author":"Cowley","year":"2004","journal-title":"Drugs"},{"key":"10.2353\/ajpath.2007.060455_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1525-1594.2002.07066.x","article-title":"Anemia and end-stage renal disease in the developing world","volume":"26","author":"Ma\u00efz","year":"2002","journal-title":"Artif Organs"},{"key":"10.2353\/ajpath.2007.060455_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5414\/CNP57208","article-title":"Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival","volume":"57","author":"Abbott","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000183332","article-title":"Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients","volume":"39","author":"Chandra","year":"1985","journal-title":"Nephron"},{"key":"10.2353\/ajpath.2007.060455_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1172\/JCI114280","article-title":"Erythropoietin in polycystic kidneys","volume":"84","author":"Eckardt","year":"1989","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2007.060455_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","article-title":"Angiogenesis in autosomal-dominant polycystic kidney disease","volume":"60","author":"Bello-Reuss","year":"2001","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.ki.5001725","article-title":"Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion cast study","volume":"70","author":"Wei","year":"2006","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1681\/ASN.V11147","article-title":"Peritubular capillary injury during the progression of experimental glomerulonephritis in rats","volume":"11","author":"Ohashi","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib11","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/01.ASN.0000018408.51388.57","article-title":"Peritubular capillary regression during the progression of experimental obstructive nephropathy","volume":"13","author":"Ohashi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1681\/ASN.V1271434","article-title":"Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1","volume":"12","author":"Kang","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/0785389031000458233","article-title":"HIF and oxygen sensing; as important to life as the air we breathe?","volume":"35","author":"Wiesener","year":"2003","journal-title":"Ann Med"},{"key":"10.2353\/ajpath.2007.060455_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1113\/expphysiol.2005.030924","article-title":"Hypoxia-inducible factor as a physiological regulator","volume":"90","author":"Maxwell","year":"2005","journal-title":"Exp Physiol"},{"key":"10.2353\/ajpath.2007.060455_bib15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5000221","article-title":"The VHL\/HIF oxygen-sensing pathway and its relevance to kidney disease","volume":"69","author":"Haase","year":"2006","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","article-title":"Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys","volume":"13","author":"Rosenberger","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1046\/j.1523-1755.2003.00159.x","article-title":"Cellular responses to hypoxia after renal segmental infarction","volume":"64","author":"Rosenberger","year":"2003","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1523-1755.2005.67110.x","article-title":"Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia","volume":"67","author":"Rosenberger","year":"2005","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.1994.253","article-title":"Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease","volume":"46","author":"Sch\u00e4fer","year":"1994","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib20","first-page":"2582","article-title":"A new rat model for polycystic kidney disease of humans","volume":"22","author":"Kaspareit-Rittinghausen","year":"1990","journal-title":"Transplant Proc"},{"key":"10.2353\/ajpath.2007.060455_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fj.02-0445fje","article-title":"Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs","volume":"17","author":"Wiesener","year":"2003","journal-title":"FASEB J"},{"key":"10.2353\/ajpath.2007.060455_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1096\/fj.04-1640fje","article-title":"Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells","volume":"18","author":"Warnecke","year":"2004","journal-title":"FASEB J"},{"key":"10.2353\/ajpath.2007.060455_bib23","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1097\/01.ASN.0000076075.49819.9B","article-title":"Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion","volume":"14","author":"Streets","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib24","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V92.7.2260","article-title":"Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha","volume":"92","author":"Wiesener","year":"1998","journal-title":"Blood"},{"key":"10.2353\/ajpath.2007.060455_bib25","first-page":"674","article-title":"Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney","volume":"73","author":"Heilig","year":"1995","journal-title":"Lab Invest"},{"key":"10.2353\/ajpath.2007.060455_bib26","first-page":"F240","article-title":"Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney","volume":"268","author":"Simon","year":"1995","journal-title":"Am J Physiol"},{"key":"10.2353\/ajpath.2007.060455_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.ki.5000062","article-title":"Expression of hypoxia-inducible transcription factors in developing human and rat kidneys","volume":"69","author":"Bernhardt","year":"2006","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-8140(03)00010-0","article-title":"Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas","volume":"67","author":"Nordsmark","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.2353\/ajpath.2007.060455_bib29","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.V94.5.1561","article-title":"Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1","volume":"94","author":"Hellwig-B\u00fcrgel","year":"1999","journal-title":"Blood"},{"key":"10.2353\/ajpath.2007.060455_bib30","doi-asserted-by":"crossref","first-page":"38183","DOI":"10.1074\/jbc.M302244200","article-title":"Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation","volume":"278","author":"D'Angelo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.060455_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.semcdb.2005.03.001","article-title":"The HIF pathway in cancer","volume":"16","author":"Maxwell","year":"2005","journal-title":"Semin Cell Dev Biol"},{"key":"10.2353\/ajpath.2007.060455_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2005.06.016","article-title":"Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity","volume":"8","author":"Moeller","year":"2005","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2007.060455_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4161\/cbt.3.6.961","article-title":"Small molecule-mediated anti-cancer therapy via hypoxia-inducible factor-1 blockade","volume":"3","author":"Macpherson","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"10.2353\/ajpath.2007.060455_bib34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/01.ASN.0000135059.67385.5D","article-title":"Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion","volume":"15","author":"Sharples","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib35","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"93","author":"Ribatti","year":"1999","journal-title":"Blood"},{"key":"10.2353\/ajpath.2007.060455_bib36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ki.1996.395","article-title":"Renal involvement in von Hippel-Lindau disease","volume":"50","author":"Chauveau","year":"1996","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2007.060455_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.2353\/ajpath.2007.060455_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2007.060455_bib39","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","article-title":"Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor","volume":"66","author":"Rankin","year":"2006","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2007.060455_bib40","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2006020181","article-title":"Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein","volume":"17","author":"Esteban","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib41","first-page":"F1159","article-title":"An incredible decade for the primary cilium: a look at a once-forgotten organelle","volume":"289","author":"Davenport","year":"2005","journal-title":"Am J Physiol"},{"key":"10.2353\/ajpath.2007.060455_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2007.060455_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.2353\/ajpath.2007.060455_bib44","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"From the cover: the mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2007.060455_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nm1337","article-title":"Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer","volume":"12","author":"Thomas","year":"2006","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2007.060455_bib46","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1242\/jcs.02648","article-title":"The insulin-PI3K\/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-alpha\/Sima","volume":"118","author":"Dekanty","year":"2005","journal-title":"J Cell Sci"},{"key":"10.2353\/ajpath.2007.060455_bib47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4161\/cc.3.2.689","article-title":"HIF-1: a target for cancer, ischemia and inflammation\u2014too good to be true?","volume":"3","author":"Melillo","year":"2004","journal-title":"Cell Cycle"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010609054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010609054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T23:39:23Z","timestamp":1628465963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010609054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0002944010609054"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2007.060455","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}